Concerning the ERCC1 rs10412761 SNP, previous studies on populations of predominantly European ancestry (USA) with pancreatic and ovarian cancer treated with several therapeutic strategies found no significant association between this SNP and survival or time to cancer recurrence [70,71]. This evidence concerns the gene ERCC1 and ovarian carcinoma.